Two new preparations are under clinical trial for use in the treatment of ulcerative proctitis and left-sided colitis. One is 5-aminosalicylate, a component of sulfasalazine. This substance has virtually no immunomodulating capabilities.
http://ift.tt/1ttDte9
via IFTTT
http://ift.tt/1ttDte9
via IFTTT
No comments:
Post a Comment